Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pharmaceuticals in the Environment: What we know and need to know 2009 Symposium on Pharmaceuticals in the Home and Environment Northport, Maine October 18-19, 2009 Herb Buxton USGS Toxic Substances Hydrology Program U.S. Department of the Interior U.S. Geological Survey 2 Chemicals of Emerging Environmental Concern: Emerging Contaminants Not Just Pharmaceuticals! Chemicals that: • interact in their affect on organisms, & • co-occur in the environment. 3 Modes of Action with Chemical Interactions • Endocrine Disruption (biogenic hormones, synthetic hormones, hormone mimics & blockers) • Antimicrobial Resistance (synthetic antimicrobials, natural antimicrobials, metals, pesticides?) 4 Emerging Contaminants • Human & Veterinary Pharmaceuticals • Detergents • Antioxidants • Fire retardants • Disinfectants • Fumigants • Fragrances • Pesticides/ Repellants • • • • • • • Industrial Chem’s, HPVs Some Metals Biogenic Hormones Phytoestrogens Natural antimicrobials Natural pesticides Degradates/ Metabolites 5 Framing Research Questions • • Are Pharm’s entering our environment? • • Are there sensitive environmental settings? • Do Pharm’s persist to finished drinking water and are they a human health risk? • How can we minimize their entry to the environment or remove them? What are the source pathways, their chemical signatures/loads? Do Pharm’s have adverse ecological health effects? 6 Are Emerging Contaminants entering our natural environment? 7 National Surveys of “Susceptible” Waters High density of population and animal production. Surface (139) 100 Present in complex mixtures. 80 Percent Detected Present in water at sub-ppb concentrations Ground (47) 60 40 20 Greater levels in streams than wells 0 N . on ug r d s ti n A s ic ot i b Ph m ar s D .M et a et b. D T EE C a e in e ff Fl uo tin e x e Kolpin, et al., 2002; Barnes et al., 2008 0% Miconazole Gemfibrozil Fluoxetine Thiabendazole Erythromycin Metformin Cimetidine Carbamazapine Water (30) Diphenhydramine Caffeine Ranitidine Acetaminophen 80% Diltiazem Dehydronifedipine Trimethoprim Cotinine Codeine Sulfamethoxazole Percent Detected 8 Don’t just look in stream waters! Sediment (36) 60% 40% 20% Furlong, et al., 2003 9 Measurement Capabilities • • • Clofibric Acid (Buser 1998) 32 drugs in German WWTPs (Ternes 1998) 45 drugs in US Rivers (Kolpin et al. 2002) • • • • • • • amphetamines antibiotics antidepressants (SSRIs) antiphlogistics antivirals barbiturates beta-blockers • • • • • • • Ca channel blocker contraceptives cytostatics fibrates glucocorticoids muscle relaxants opioids 10 What are the source pathways to the environment and their chemical signatures/loads? 11 Human Source Pathways? • WW Treatment Plants • • • • Domestic Septic Systems Land Application Industrial/Commercial Discharges Landfills • Water Reuse 12 Animal Source Pathways? • Grazing • AFOs/CAFOs • Waste lagoons • Land application • Processing • Aquaculture • Pets 13 WWTP Discharges to Streams • Complex chemical mixtures. • Multiple upstream WWTP discharges. • Significant % WW in some streams (arid or urbanized watersheds). 14 ECs in Biosolids Destined for Land App Carbon Norm. Concentration (mg/kg,10-40% C) Carbemazepine Diphenhydramine Fluoxetine Triclosan Range 15-1,200 32-22,000 100-4,700 1,170-32,900 Median 68 340 370 10,200 • Biosolids from 9 sites • 53 (of 87) ECs detected • 30 to 45 in each biosolid • 25 in all samples Kinney et al., 2006 15 Septic Systems ECs found in septic wastewaters and adjacent groundwater (Swartz et al., 2006; Carrara et al., 2008) Higher levels in commercial than domestic septics (restaurants, convenience stores, retail centers, schools, veterinary hospitals) (Conn et al., 2006) 16 Conc. Animal Feeding Operations • Large facilities • Prophylactic doses • Antibiotics, growth promoters, estrus modulators, … Manure (kg/day) Human Cow Hog Sheep Chicken 1.5 30 4 1.5 0.14 lo r su ot lfa et-t m ota et ha l lin zin co e m te y tra cin ox c yt ycl et ra ine su cyc lfa lin e th ia zo su le lfa t y er dim los yt i hr eth n om ox yc ine tri in-H su me 2O lfa th o m et prim h vi oxa rg in zole su iam lfa y m cin et hi zo le To ta l ch Detections (%) 17 Antibiotics in Swine Lagoons 100 90 80 70 60 Antibiotics in 46 Swine AFOs 50 40 30 20 10 0 Meyer et al., 2003 18 Are there sensitive environmental settings? 19 Hospital Effluents (Antibiotics) 3 Hospitals in Southeast Queensland, Australia 16 of the 27 antibiotics detected. Watkinson et al., 2009 20 Pharm. Manufacturing Facilities WWTP near Hyderabad India • Receives effluent from 90 bulk drug manufacturers. • Samples on consecutive days. Active Ingredient Ciprofloxacin Drug Type Range (mg/L) antibiotic 28,000-31,000 Losartan angiotensin II receptor antagonist 2,400-2,500 Cetrizine H1-receptor antagonist 1,300-1,400 Metoprolol B1-andrenoreceptor antagonist 800-950 Antibiotic 780-900 Citalopram SSRI 770-840 Norfloxacin antibiotic 390-420 Lomefloxacin antibiotic 150-300 Enoxacin antibiotic 150-300 Ofloxacin antibiotic 150-160 Enrofloxacin Larsson et al., 2007 21 Hydrologic Events Spring Flush Cedar Rapids, IA Midwest Floods, Spring ‘08 21 herbicides, 27 degradates, 36 antibiotics in 51 Midwest Streams Scribner et al., 2003 22 Animal Waste Lagoon Failure Aug 24, 2009 Sept 8, 2009 Sept 14, 2009 Sept 21, 2009 Midwest Headwaters Stream 23 Do EC’s have adverse ecological health effects? 24 EC Uptake in Organisms Plant Tissue Animal Tissue • Oxytetracycline in alfalfa (Kong et al., 2007). • • Oxytetracycline, flumequine & oxolinic acid in bryophytes (Delepee et al., 2004). Fluoxetine in bluegill, catfish, carp, crappie (Brooks et al., 2005). • Gemfibrozil in goldfish (Mimeault et al, 2005). • Trimethoprim in carrots & lettuce (Boxall et al., 2006). • Triclosan & Methyl-triclosan in carp (Leiker et al., 2008). • Sulfamethazine in corn, lettuce, potatoes (Dolliver, et al., 2007). • Trimethoprim & Triclosan in earthworms (Kinney et al., 2008). 25 Ecological Effects • Antibiotics: Reduced soil microbial activity at env. concentrations (Costanzo et al., 2005; Thiele-Bruhn and Beck, 2005). • Diclofenac (NSAID): Consumption of diclofenac-treated meat caused renal failure in vultures (Oaks et al., 2004). • Ciprofloxacin, triclosan, Tergitol NP 10: shifts in algal community structure (Wilson et al., 2003) . • Drug Mixtures 13: Inhibited growth of human embryonic cells at environmental levels (Pomati et al., 2006, 2008). • Fluoxetine: Affected reproduction in freshwater molluscs -- water-sediment exchange (Sanchez-Arguello et al., 2009). • Antidepressants: (environmental levels) Affected predator avoidance behavior of larval fathead minnow (McGee et al. 2009). • 4-nonylphenol: (environmental exposures) Impaired reproductive potential of male fathead minnows. (Schoenfuss et al., 2008). • Alkylphenolethoxylates: (environmental mixtures) Reduced reproductive competence in male fathead minnows (Bistodeau et al., 2006). • Sewage Sludge: Affected bone homeostasis in sheep (Lind et al., 2009). 26 Endocrine Disruption: A Case Study Boulder Creek, CO <0.8 Low-head Dam 2.1 Boulder WWTP 1.4 2.9 1.2 17b-Estradiol in stream water, in ng/L Vajda et al., 2008 27 Estrogenicity of Boulder Effluent & Boulder Creek Non-hormone EACs Estrone 17β-Estradiol 17α-Ethynylestradiol Total Estrogen Equivalency (in ng L-1 17β-Estradiol) 30 25 20 15 10 5 0 Reference Site WWTP Effluent Effluent Site Spring 2005 Vajda et al., 2008 28 Endocrine Effects in Boulder Ck (White Sucker) Sex, in Percent Female Intersex Male 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Blood Vitellogenin Cellular Abnormalities male Upstream Intersex 0% Downstream 18-Jun-04 19% female Vajda et al., 2008 29 Do EC’s persist to finished drinking water and are they a human health risk? 30 National Source Water Survey 60 Source-water reconnaissance (surface-water sites) 50 DW Sources (Streams) 49 Susceptible Streams 139 40 Stream reconnaissance (Kolpin, et al., 2002) 30 20 10 dr tylo on sin su i lfa fed ip m in et ho e xa lin zol er e co yt hr m om yc in ac ycin et om H2 O in op tri 1, he m 7n et di h m op et rim hy lx an th in co e tin in e de hy az em 0 di lti Percent Detection Frequency of Detection, in percent Natural Dilution and Degradation Focazio et al., 2008 31 ECs in Finished Drinking Water *11 of 20 Pharm’s not detected 18 DW Facilities Detections 14 15 Max. (ppt) 42 Pharm’s PCPs 12 10 8 6 4 2 19 18 18 2.1 470 93 510 3 0.82 100 0.33 1.2 25 ba m at e ph en yto in at ca e no rb am lol az ep in ge e m f ib ro zil TC EP DE ET su lf a TC m PP et ho xa zo le flu ox et no ny ine lph en ol dia ze pa m tri cl o sa bis n ph en ol A 0 ep ro Supported by AWWA Research Fnd. & WateReuse Fnd. 16 m Conducted by Southern Nevada Water Authority Detections in 18 Samples 18 Benotti et al., 2008 32 Human Health Risk? • Chronic low-level exposure. • Exposure to chemical mixtures. • Sensitive subpopulations. • Can we prioritize chemicals systematically for effects studies? 33 How can we minimize their entry to the environment or remove them? 34 WWTPs Ability To Reduce ECs trickling filter activated sludge A B C D Plant Phillips et al., 2008 35 Removal in Treatment, NJ Facility Finished Water Percent Detection Percent Detection Raw Water Levels Generally Reduced by Treatment with GAC Filters Pharmaceutical/Antibiotic Flame retardant/Plasticizer Fragrance Pesticide Plant/Animal steroid Detergent metabolite PAHs Others Stackelberg et al., 2004 & 2007 36 Thank you! And thanks to the many researchers who provided the information presented. For more info on USGS EC research: http://toxics.usgs.gov